Market Overview

Citigroup Downgrades Boston Scientific Corporation to Neutral, Raises PT to $9.30

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BSX

DateFirmActionFromTo
May 2017Goldman SachsInitiates Coverage OnNeutral
Oct 2016CitigroupMaintainsBuy
Sep 2016Argus ResearchUpgradesHoldBuy

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (BSX)